Compare
Nutex Health Inc. vs XBP Global Holdings, Inc. vs Priority Technology Holdings, Inc. vs Claritev Corp
| Latest fiscal year | Nutex Health Inc. NUTX | XBP Global Holdings, Inc. XBPLast annual report: year ended 2024-12-31 | Priority Technology Holdings, Inc. PRTH | Claritev Corp CTEV |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2024-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $875.26M | $872.69M | $953.01M | $965.41M |
| Revenue growth (YoY) | +82.4% | n/a | +8.3% | +3.7% |
| Gross margin | 50.8% | 21.6% | n/a | n/a |
| Operating margin | 31.5% | -12.1% | 14.8% | 3.0% |
| Net margin | 8.1% | -24.7% | 5.8% | -29.4% |
| Net income | $70.79M | -$215.15M | $55.68M | -$284.28M |
| EPS (Diluted) | $10.48 | $0.41 | $0.68 | -$17.30 |
| Operating cash flow | $248.12M | $23.27M | $100.00M | $117.32M |
| Free cash flow | $245.60M | $16.97M | $75.08M | -$12.28M |
| Cash & equivalents | $185.57M | $11.63M | $77.19M | $16.81M |
| Total assets | $918.52M | $390.42M | $2.40B | $4.89B |
| Total liabilities | $495.09M | $1.85B | $2.49B | $5.06B |
| Shareholders' equity | $423.44M | -$1.46B | -$100.42M | -$173.90M |
| Return on year-end equity | 16.7% | n/a | n/a | n/a |
| Shares outstanding | 7.09M | 30.17M | 81.91M | 16.55M |
Revenue, most recent five fiscal years
| Fiscal year | Nutex Health Inc. | XBP Global Holdings, Inc. | Priority Technology Holdings, Inc. | Claritev Corp |
|---|---|---|---|---|
| Latest | $875.26M Ended 2025-12-31 | $872.69M Ended 2024-12-31 | $953.01M Ended 2025-12-31 | $965.41M Ended 2025-12-31 |
| 1 year earlier | $479.95M Ended 2024-12-31 | n/a | $879.70M Ended 2024-12-31 | $930.62M Ended 2024-12-31 |
| 2 years earlier | $247.65M Ended 2023-12-31 | n/a | $755.61M Ended 2023-12-31 | $961.52M Ended 2023-12-31 |
| 3 years earlier | $219.29M Ended 2022-12-31 | n/a | $663.64M Ended 2022-12-31 | $1.08B Ended 2022-12-31 |
| 4 years earlier | $331.53M Ended 2021-12-31 | n/a | $514.90M Ended 2021-12-31 | $1.12B Ended 2021-12-31 |